We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+6.92%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$31.1B
AUM Growth
+$1.68B
Cap. Flow
+$21M
Cap. Flow %
0.07%
Top 10 Hldgs %
14.12%
Holding
3,080
New
66
Increased
2,426
Reduced
529
Closed
46

Top Buys

Rank Stock Value
1
CB icon
Chubb
CB
+$39M
2
HPE icon
Hewlett Packard
HPE
+$35.3M
3
SYF icon
Synchrony
SYF
+$29.5M
4
CMCSA icon
Comcast
CMCSA
+$25.4M
5
ILMN icon
Illumina
ILMN
+$13.5M

Sector Composition

Rank Sector Weight
1 Financials 15.31%
2 Healthcare 14.62%
3 Technology 14.1%
4 Industrials 10.66%
5 Consumer Discretionary 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSBC icon
2576
Old Second Bancorp
OSBC
$1.32B
$302K ﹤0.01%
38,466
+1,835
+5% +$13.2K
PRTY
2577
DELISTED
Party City Holdco Inc.
PRTY
$302K ﹤0.01%
23,413
+1,835
+9% +$26.4K
SIGM
2578
DELISTED
Sigma Designs Inc
SIGM
$301K ﹤0.01%
47,552
+2,215
+5% +$17.5K
MFLX
2579
DELISTED
MULTI-FINELINE ELECTRONIX INC
MFLX
$300K ﹤0.01%
14,496
+125
+0.9% +$2.61K
ESPR
2580
DELISTED
Esperion Therapeutics
ESPR
$299K ﹤0.01%
13,449
+1,375
+11% +$34.7K
PDFS icon
2581
PDF Solutions
PDFS
$2.07B
$299K ﹤0.01%
27,593
+1,975
+8% +$21.4K
CLMS
2582
DELISTED
Calamos Asset Management, Inc.
CLMS
$299K ﹤0.01%
30,877
+530
+2% +$4.99K
ASC icon
2583
Ardmore Shipping
ASC
$671M
$298K ﹤0.01%
23,391
+370
+2% +$4.66K
LAB icon
2584
Standard BioTools
LAB
$307M
$298K ﹤0.01%
27,606
+2,110
+8% +$20.7K
MLAB icon
2585
Mesa Laboratories
MLAB
$574M
$298K ﹤0.01%
2,998
+276
+10% +$29.5K
NC icon
2586
NACCO Industries
NC
$356M
$298K ﹤0.01%
30,910
+175
+0.6% +$1.78K
LOXO
2587
DELISTED
Loxo Oncology, Inc
LOXO
$298K ﹤0.01%
+10,472
New +$281K
BSRR icon
2588
Sierra Bancorp
BSRR
$528M
$297K ﹤0.01%
16,810
+730
+5% +$12.6K
ZAGG
2589
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$297K ﹤0.01%
27,150
+2,375
+10% +$22.6K
BEAT
2590
DELISTED
BioTelemetry, Inc.
BEAT
$297K ﹤0.01%
25,432
+1,965
+8% +$24.9K
BELFB
2591
Bel Fuse Inc Class B
BELFB
$4.18B
$296K ﹤0.01%
17,114
+470
+3% +$8.99K
KPTI icon
2592
Karyopharm Therapeutics
KPTI
$43.3M
$295K ﹤0.01%
1,483
+100
+7% +$21.7K
WEYS icon
2593
Weyco Group
WEYS
$418M
$295K ﹤0.01%
11,038
+420
+4% +$11.6K
PHIIK
2594
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$294K ﹤0.01%
17,941
-470
-3% -$9.37K
KOPN icon
2595
Kopin
KOPN
$732M
$293K ﹤0.01%
107,623
+3,960
+4% +$11.6K
NOK icon
2596
Nokia
NOK
$53.5B
$293K ﹤0.01%
41,712
+1,840
+5% +$13.1K
CAI
2597
DELISTED
CAI International, Inc.
CAI
$293K ﹤0.01%
29,110
+795
+3% +$8.49K
NUTR
2598
DELISTED
Nutraceutical International Co
NUTR
$293K ﹤0.01%
11,363
-510
-4% -$12.5K
XCO
2599
DELISTED
Exco Resources
XCO
$293K ﹤0.01%
15,737
+26
+0.2% +$430
BGFV
2600
DELISTED
Big 5 Sporting Goods
BGFV
$292K ﹤0.01%
29,233
+330
+1% +$3.25K

Similar funds

RhumbLine Advisers's Q4 2015 Portfolio in Review

As of Q4 2015, RhumbLine Advisers held 3,080 positions worth $31.1B, up 5.7% from $29.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q4 2015: portfolio turnover was 3.6%. RhumbLine Advisers opened 66 new positions and exited 46, leaving the 3,080-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

  • RhumbLine Advisers's largest Q4 2015 buy was Hewlett Packard: 4,220,807 shares worth $37.3M.
  • RhumbLine Advisers added most to Chubb in Q4 2015, an estimated $39M increase.
  • RhumbLine Advisers's biggest Q4 2015 reduction was HP, cutting an estimated $38.8M.
  • RhumbLine Advisers fully exited CHUBB CORPORATION in Q4 2015, selling an estimated $43M.
  • RhumbLine Advisers's ten largest holdings make up 14% of its $31.1B portfolio in Q4 2015.
  • RhumbLine Advisers opened 66 new positions and closed 46 in Q4 2015.
  • RhumbLine Advisers's portfolio value rose 5.7% quarter-over-quarter to $31.1B.

Based on RhumbLine Advisers's 13F filing for Q4 2015, filed 3 Feb 2016.